Compared with the model group, Rb1 reduced myocardial infarction size, and caspase-3 activity, TNF-α levels, and phosphorylated p38 MAPK levels were also reduced by Rb1 pretreatment (Figure 3A; Li and Ji, 2018). The gene discussed is CASP3; the disease is myocardial infarction.